home / stock / psyg:cc / psyg:cc news

PSYG:CC News and Press, Psyence Group Inc. From 11/15/23

Stock Information
Company Name: Psyence Group Inc.
Stock Symbol: PSYG:CC
Market: CNQC
Website: psyence.com
Menu
PSYG:CC PSYG:CC Quote PSYG:CC Short PSYG:CC News PSYG:CC Articles PSYG:CC Message Board
Get PSYG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PSYG:CC - Canadian Investment Regulatory Organization Trade Resumption - PSYG

Canadian Investment Regulatory Organization Trade Resumption - PSYG Canada NewsWire VANCOUVER, BC , Nov. 15, 2023 /CNW/ - Trading resumes in: Company: Psyence Group Inc. CSE Symbol: PSYG All Issues: Yes Resumption (ET): 1:30 pm CIR...
PSYG:CC - Canadian Investment Regulatory Organization Trading Halt - PSYG

Canadian Investment Regulatory Organization Trading Halt - PSYG Canada NewsWire VANCOUVER, BC , Nov. 15, 2023 /CNW/ - The following issues have been halted by CIRO: Company: Psyence Group Inc. CSE Symbol: PSYG All Issues: Yes Reason: Pending C...

PSYG:CC - Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp

TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing (“Psyence”), and Newcourt Acquisition Corp (Nasdaq: NCAC) (“Newcourt&#x...

PSYG:CC - Psyence Production Expands Capability

TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc . (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing (“ Psyence ”), is pleased to provide the following update on Psyenc...
PSYG:CC - Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement

TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB:PSYGF) (“Psyence” or the “Company”) , a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, announces that it has issued 1...

PSYG:CC - Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

VANCOUVER, British Columbia, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being (“ Psyence ”), and Newcourt Acquisition C...

PSYG:CC - Psyence Appoints Intellectual Property Expert to Its Board of Directors

TORONTO, July 11, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“ Psyence ” or the “ Company ”) is pleased to announce the appointment of Christopher Bull to the board of directors of the Company effective immediately. Mr...
PSYG:CC - Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Psyence Group inc. (CSE:PSYG | OTCQB:PSYGF) ("Psyence" or the "Company"), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that it has issued 9,043,038 common...

PSYG:CC - Psyence Group Announces Cantheon Capital Private Placement

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc ( CSE:PSYG | OTCQB: PSYGF ), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce that it has entered into...

PSYG:CC - Psyence Partners with iNGEN? for Palliative Care Clinical Trial in Australia

VANCOUVER, British Columbia, March 21, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc ( CSE:PSYG | OTCQB: PSYGF ), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce that its newly incorpora...
Previous 10 Next 10